Bioinvision Inc.
Cleveland, OH
- UEI
- DPL8U7UN1435
- CAGE
- 47ZU6
- Primary NAICS
- 334516 Analytical Laboratory Instrument Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 781 Beta Dr e, Cleveland, OH 44143, USA
- Website
- bioinvision.com
- Employees
- 1-10
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract subawards
| Prime contractor | Prime award | Amount | Awarded |
|---|---|---|---|
| Case Western Reserve University | 75N98022C00018 | $68,684 |
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
About the company
Bioinvision Inc. is a biotechnology research company that specializes in providing advanced imaging solutions for studying cellular sensitivity. Their flagship product, CryoViz Imaging, allows researchers to track the movement of labeled cells, monitor therapeutic delivery, and conduct gene expression analysis. Bioinvision is registered in SAM.gov as a Minority Owned Business, Self Certified Small Disadvantaged Business, For Profit Organization, and Subcontinent Asian (Asian-Indian) American Owned corporate entity.
Through federal contract awards, Bioinvision Inc. has served as a subcontractor to Case Western Reserve University. They provided design, manufacturing, training, support, and equipment for 3D-MUSE imaging systems used in a project funded by the National Institutes of Health (NIH) SPARC program. This project aimed to conduct multimodal, multiscale imaging of human vagus nerves to support the development of neuromodulation therapies for autonomic regulation. Bioinvision's role involved ensuring minimal downtime for the imaging systems, assisting with standard operating procedures, providing documentation, and collaborating on system improvements like light-tight enclosures and streamlined software.
Bioinvision Inc. has received prime federal grant awards from the National Institutes of Health (NIH) to develop innovative imaging technologies and software solutions. In one project funded by the National Institute of General Medical Sciences, they were awarded $448,414 to commercialize an AI-based 3D tissue imaging solution for preclinical applications. This solution employs automatic deep-learning tissue recognition and semi-automated tissue recovery from whole organisms, enabling high-resolution fluorescence imaging and image-guided histology for applications like oncology, drug delivery, and gene expression studies. Another project, funded by the National Heart, Lung and Blood Institute with $2,010,986, aims to develop software for quantitative analysis of cardiac computed tomography perfusion data. This software will help cardiologists identify functional flow deficits in coronary artery territories, discriminate cardiac microvascular disease, and harmonize blood flow measurements across CT acquisition systems, improving cardiovascular disease management.
Quick answers
Is Bioinvision Inc. registered in SAM.gov?
Yes. Bioinvision Inc.'s SAM.gov registration is active through November 20, 2026.
What is Bioinvision Inc.'s most recent federal award?
Bioinvision Inc.'s most recent federal grant award is Tissuerem: whole-organism, real-time decision-enabled 3D tissue imaging and recovery for molecular analysis (R44GM145205), from National Institute of General Medical Sciences (NIH), on August 5, 2022.
On GovTribe
See Bioinvision Inc.'s full federal record
- Federal grant awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors